this issue
previous article in this issuenext article in this issue

Document Details :

Title: Fondaparinux in heparin-induced thrombocytopenia
Author(s): A. Gevaert , H. Smets , R. Vercauteren
Journal: Acta Cardiologica
Volume: 68    Issue: 5   Date: 2013   
Pages: 517-520
DOI: 10.2143/AC.68.5.2994477

Abstract :
Heparin-induced thrombocytopenia is a potentially life-threatening complication of heparin or low-molecular-weight heparin administration. We describe the case of a patient with heparin-induced thrombocytopenia complicated by pulmonary embolism, successfully treated with fondaparinux, a factor Xa inhibitor. We also review the literature regarding the use of this anticoagulant in heparin-induced thrombocytopenia complicated by thrombosis. Few treatment options are available in Belgium, and there is little evidence regarding newer anticoagulants.